| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Bronchoscopy | 4 | 2021 | 991 | 1.44 | Why? |
| Sarcoidosis, Pulmonary | 2 | 2017 | 91 | 1.22 | Why? |
| Legionellosis | 1 | 2021 | 31 | 0.93 | Why? |
| Prone Position | 3 | 2021 | 1861 | 0.84 | Why? |
| Laryngeal Cartilages | 1 | 2019 | 7 | 0.83 | Why? |
| Wind | 1 | 2021 | 144 | 0.81 | Why? |
| Patient Positioning | 2 | 2021 | 1505 | 0.80 | Why? |
| Wakefulness | 2 | 2021 | 598 | 0.76 | Why? |
| Hospitals, Rural | 1 | 2021 | 185 | 0.73 | Why? |
| Radiographic Image Enhancement | 1 | 2018 | 89 | 0.72 | Why? |
| Glutathione S-Transferase pi | 1 | 2017 | 10 | 0.71 | Why? |
| Anesthesia, Local | 1 | 2019 | 163 | 0.68 | Why? |
| Iodine | 1 | 2018 | 116 | 0.67 | Why? |
| Arm | 1 | 2018 | 159 | 0.66 | Why? |
| Lidocaine | 1 | 2018 | 94 | 0.66 | Why? |
| Social Change | 1 | 2020 | 303 | 0.65 | Why? |
| Mercury Poisoning | 1 | 2015 | 7 | 0.64 | Why? |
| Tuberculosis, Pulmonary | 2 | 2017 | 1171 | 0.64 | Why? |
| Epigenomics | 1 | 2017 | 139 | 0.62 | Why? |
| Hemoptysis | 1 | 2018 | 172 | 0.61 | Why? |
| Anesthetics, Local | 1 | 2018 | 205 | 0.58 | Why? |
| Mercury | 1 | 2015 | 95 | 0.57 | Why? |
| Humidity | 1 | 2021 | 944 | 0.54 | Why? |
| Rural Health Services | 1 | 2021 | 496 | 0.53 | Why? |
| Temperature | 2 | 2021 | 2305 | 0.53 | Why? |
| India | 16 | 2021 | 11875 | 0.52 | Why? |
| Lung Neoplasms | 5 | 2017 | 3228 | 0.52 | Why? |
| Biomarkers, Tumor | 4 | 2017 | 1314 | 0.52 | Why? |
| Endemic Diseases | 1 | 2016 | 480 | 0.48 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.47 | Why? |
| Biopsy | 3 | 2020 | 2811 | 0.47 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.41 | Why? |
| Oxygen | 2 | 2021 | 3715 | 0.41 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.38 | Why? |
| Computed Tomography Angiography | 1 | 2018 | 2153 | 0.36 | Why? |
| Gastrointestinal Tract | 1 | 2015 | 1113 | 0.34 | Why? |
| Lung Diseases | 1 | 2021 | 2361 | 0.33 | Why? |
| Lung Diseases, Interstitial | 1 | 2017 | 1476 | 0.30 | Why? |
| Sleep Apnea, Obstructive | 3 | 2018 | 668 | 0.29 | Why? |
| Cough | 1 | 2019 | 4891 | 0.28 | Why? |
| Consensus | 2 | 2019 | 6345 | 0.28 | Why? |
| Point-of-Care Testing | 1 | 2018 | 2782 | 0.28 | Why? |
| Serologic Tests | 1 | 2017 | 4359 | 0.25 | Why? |
| Hyperhomocysteinemia | 1 | 2002 | 24 | 0.24 | Why? |
| Diet, Vegetarian | 1 | 2002 | 31 | 0.24 | Why? |
| Ultrasonography | 2 | 2018 | 4409 | 0.24 | Why? |
| Infection Control | 3 | 2021 | 23131 | 0.23 | Why? |
| Molecular Diagnostic Techniques | 2 | 2017 | 4239 | 0.23 | Why? |
| Homocysteine | 1 | 2002 | 83 | 0.23 | Why? |
| Kidney | 1 | 2015 | 3648 | 0.22 | Why? |
| Vitamin B 12 | 1 | 2002 | 132 | 0.21 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.21 | Why? |
| Folic Acid | 1 | 2002 | 172 | 0.21 | Why? |
| Pulmonary Atelectasis | 1 | 2021 | 80 | 0.21 | Why? |
| Chromatography | 1 | 2021 | 112 | 0.21 | Why? |
| Exudates and Transudates | 1 | 2020 | 92 | 0.21 | Why? |
| Diagnostic Techniques, Respiratory System | 1 | 2021 | 114 | 0.21 | Why? |
| Primary Health Care | 1 | 2019 | 4839 | 0.21 | Why? |
| Radiotherapy, Intensity-Modulated | 2 | 2019 | 148 | 0.20 | Why? |
| Thoracoscopy | 1 | 2020 | 113 | 0.20 | Why? |
| Carcinoma, Non-Small-Cell Lung | 3 | 2017 | 896 | 0.19 | Why? |
| Humans | 50 | 2021 | 930598 | 0.19 | Why? |
| Radiotherapy Dosage | 2 | 2019 | 428 | 0.19 | Why? |
| Radiography, Dual-Energy Scanned Projection | 1 | 2018 | 53 | 0.19 | Why? |
| Pleura | 1 | 2020 | 178 | 0.19 | Why? |
| Injections | 1 | 2019 | 237 | 0.18 | Why? |
| Pain Measurement | 2 | 2020 | 533 | 0.18 | Why? |
| Registries | 2 | 2021 | 12327 | 0.18 | Why? |
| Lung Diseases, Obstructive | 1 | 2017 | 46 | 0.17 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2020 | 260 | 0.16 | Why? |
| Health Services Accessibility | 1 | 2021 | 10697 | 0.16 | Why? |
| Breast | 1 | 2019 | 290 | 0.16 | Why? |
| Tertiary Healthcare | 1 | 2021 | 616 | 0.16 | Why? |
| Radiotherapy, Adjuvant | 1 | 2017 | 180 | 0.16 | Why? |
| Biopsy, Fine-Needle | 1 | 2017 | 274 | 0.16 | Why? |
| Pulmonary Embolism | 1 | 2015 | 4775 | 0.16 | Why? |
| Undifferentiated Connective Tissue Diseases | 1 | 2016 | 60 | 0.16 | Why? |
| Hyperemia | 1 | 2016 | 62 | 0.15 | Why? |
| Respiratory Rate | 1 | 2020 | 691 | 0.15 | Why? |
| Tertiary Care Centers | 4 | 2021 | 8248 | 0.15 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.15 | Why? |
| ErbB Receptors | 1 | 2017 | 320 | 0.15 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2017 | 2309 | 0.14 | Why? |
| Proto-Oncogene Proteins | 1 | 2017 | 340 | 0.14 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.14 | Why? |
| Lung | 5 | 2021 | 31049 | 0.14 | Why? |
| Administration, Inhalation | 2 | 2018 | 1647 | 0.14 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.14 | Why? |
| Patient Participation | 1 | 2021 | 829 | 0.13 | Why? |
| Pathology, Molecular | 1 | 2017 | 343 | 0.13 | Why? |
| Pleural Effusion | 1 | 2020 | 680 | 0.13 | Why? |
| B7-H1 Antigen | 1 | 2017 | 541 | 0.13 | Why? |
| Nephrotic Syndrome | 1 | 2015 | 146 | 0.13 | Why? |
| Nebulizers and Vaporizers | 1 | 2017 | 497 | 0.13 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.12 | Why? |
| Neoplasm Staging | 2 | 2017 | 1999 | 0.12 | Why? |
| Hot Temperature | 1 | 2021 | 1299 | 0.12 | Why? |
| Hospital Bed Capacity | 1 | 2021 | 1300 | 0.12 | Why? |
| Reproducibility of Results | 3 | 2018 | 11304 | 0.12 | Why? |
| Diagnosis, Differential | 2 | 2017 | 7220 | 0.12 | Why? |
| Aspirin | 1 | 2020 | 1043 | 0.12 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.12 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.12 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.12 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.11 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.11 | Why? |
| Adjuvants, Immunologic | 1 | 2021 | 1709 | 0.11 | Why? |
| Physician-Patient Relations | 1 | 2021 | 1266 | 0.11 | Why? |
| Female | 20 | 2021 | 380317 | 0.11 | Why? |
| Endothelial Growth Factors | 1 | 2009 | 5 | 0.11 | Why? |
| Feasibility Studies | 2 | 2018 | 3467 | 0.11 | Why? |
| Organizational Innovation | 1 | 2021 | 2468 | 0.10 | Why? |
| Male | 20 | 2021 | 367725 | 0.10 | Why? |
| Adult | 18 | 2021 | 244371 | 0.10 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Double-Blind Method | 2 | 2021 | 5988 | 0.10 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.10 | Why? |
| BCG Vaccine | 1 | 2021 | 1137 | 0.10 | Why? |
| Diagnostic Errors | 1 | 2016 | 865 | 0.10 | Why? |
| Breast Neoplasms | 2 | 2019 | 3633 | 0.10 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2020 | 1671 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.10 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.10 | Why? |
| Biomarkers, Pharmacological | 1 | 2010 | 150 | 0.09 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.09 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 907 | 0.09 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.09 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 1510 | 0.09 | Why? |
| Self Care | 1 | 2017 | 918 | 0.09 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.09 | Why? |
| Mastectomy, Segmental | 2 | 2019 | 124 | 0.09 | Why? |
| Evidence-Based Medicine | 1 | 2021 | 3228 | 0.09 | Why? |
| Pneumocystis carinii | 1 | 2010 | 205 | 0.09 | Why? |
| Radiometry | 2 | 2019 | 136 | 0.09 | Why? |
| Radiotherapy Planning, Computer-Assisted | 2 | 2019 | 172 | 0.09 | Why? |
| Prospective Studies | 5 | 2020 | 43301 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Health Services Needs and Demand | 1 | 2021 | 3419 | 0.08 | Why? |
| Polysomnography | 2 | 2018 | 296 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2021 | 3543 | 0.07 | Why? |
| Pneumonia, Pneumocystis | 1 | 2010 | 322 | 0.07 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.07 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.07 | Why? |
| Endothelium, Vascular | 1 | 2016 | 1751 | 0.07 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.07 | Why? |
| DNA | 1 | 2010 | 778 | 0.07 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.07 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 2984 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.06 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2021 | 4927 | 0.06 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.06 | Why? |
| Aged | 9 | 2021 | 215776 | 0.06 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.06 | Why? |
| Mental Recall | 1 | 2002 | 77 | 0.06 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.06 | Why? |
| Anthropometry | 1 | 2002 | 233 | 0.06 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Toll-Like Receptor 8 | 1 | 2021 | 102 | 0.05 | Why? |
| Pain Perception | 1 | 2020 | 48 | 0.05 | Why? |
| Midazolam | 1 | 2020 | 79 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
| Organs at Risk | 1 | 2019 | 48 | 0.05 | Why? |
| Adenoviruses, Human | 1 | 2021 | 195 | 0.05 | Why? |
| Bronchoscopes | 1 | 2021 | 168 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Mycobacterium | 1 | 2021 | 143 | 0.05 | Why? |
| Toes | 1 | 2021 | 252 | 0.05 | Why? |
| Fentanyl | 1 | 2020 | 142 | 0.05 | Why? |
| X-Rays | 1 | 2021 | 492 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3832 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.04 | Why? |
| Acinetobacter baumannii | 1 | 2021 | 378 | 0.04 | Why? |
| Blood Chemical Analysis | 1 | 2002 | 541 | 0.04 | Why? |
| Choice Behavior | 1 | 2021 | 319 | 0.04 | Why? |
| Enterovirus | 1 | 2021 | 402 | 0.04 | Why? |
| Therapeutic Occlusion | 1 | 2016 | 2 | 0.04 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.04 | Why? |
| Toll-Like Receptor 7 | 1 | 2021 | 402 | 0.04 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.04 | Why? |
| Expectorants | 1 | 2017 | 95 | 0.04 | Why? |
| Poverty Areas | 1 | 2002 | 556 | 0.04 | Why? |
| Maintenance Chemotherapy | 1 | 2017 | 133 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2017 | 400 | 0.04 | Why? |
| Klebsiella pneumoniae | 1 | 2021 | 658 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Pulse Wave Analysis | 1 | 2016 | 221 | 0.04 | Why? |
| Radiologists | 1 | 2021 | 873 | 0.04 | Why? |
| Genetic Testing | 1 | 2018 | 395 | 0.04 | Why? |
| Hypnotics and Sedatives | 1 | 2020 | 624 | 0.03 | Why? |
| Tuberculosis | 2 | 2021 | 2895 | 0.03 | Why? |
| Prevalence | 1 | 2016 | 25773 | 0.03 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Antineoplastic Agents | 1 | 2009 | 3550 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2021 | 1562 | 0.03 | Why? |
| Antimicrobial Stewardship | 1 | 2021 | 931 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Mycobacterium tuberculosis | 1 | 2021 | 1164 | 0.03 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.03 | Why? |
| Urban Population | 1 | 2002 | 2000 | 0.03 | Why? |
| Postoperative Care | 1 | 2017 | 755 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.03 | Why? |
| Prognosis | 4 | 2018 | 32490 | 0.03 | Why? |
| DNA, Fungal | 1 | 2010 | 95 | 0.03 | Why? |
| Analgesics, Opioid | 1 | 2020 | 1070 | 0.03 | Why? |
| Autopsy | 1 | 2021 | 3495 | 0.02 | Why? |
| Cell Count | 1 | 2010 | 228 | 0.02 | Why? |
| Cytodiagnosis | 1 | 2010 | 104 | 0.02 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.02 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.02 | Why? |
| Tomography, X-Ray Computed | 3 | 2021 | 25144 | 0.02 | Why? |
| Child | 1 | 2018 | 70012 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Government | 1 | 2017 | 1453 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Patient Education as Topic | 1 | 2017 | 1476 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.02 | Why? |
| Heart Rate | 1 | 2016 | 1527 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.02 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2021 | 5486 | 0.02 | Why? |
| Leukocytes | 1 | 2010 | 1046 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Obesity | 1 | 2002 | 7388 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2016 | 7972 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2021 | 10083 | 0.01 | Why? |
| ROC Curve | 1 | 2009 | 6024 | 0.01 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.01 | Why? |
| Case-Control Studies | 1 | 2016 | 17671 | 0.01 | Why? |
| Survival Analysis | 1 | 2010 | 7592 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2010 | 6740 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 7868 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2010 | 5150 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.01 | Why? |